Analysts Caution Investors on GPT Healthcare

GPT Healthcare’s stock debuted with a 16 percent higher value than the IPO price, which exceeded the expectations of analysts. It initially began trading at Rs 215 on the NSE and Rs 216.15 on the BSE, compared to the issue price of Rs 186. However, shortly after opening, it declined to Rs 202.

According to Prathamesh Masdekar, a research analyst at StoxBox, for better financial performance, there is a need for improvement in bed occupancy rates. At present, the advice to investors is to take profits now and, in the near term, assess the company’s quarterly performance before considering reinvestment